Nile Pharma logs 11.3% YoY higher profits in 3 months
Updated 10/25/2022 10:39:00 AM
Arab Finance: El Nile Company for Pharmaceuticals and Chemical Industries (Nile Pharma) (NIPH) recorded an 11.3% year-on-year (YoY) increase in net profit after tax during the first quarter (Q1) of the fiscal year (FY) 2022/2023, according to financial indicators filed to the Egyptian Exchange (EGX) on Tuesday.
The company’s net profit after tax rose EGP 20.838 million in the three months that ended September 30th from EGP 18.715 million the year before.
Revenues surged to EGP 231.334 million in the July-September period from EGP 207.303 million a year earlier.
Nile Pharma manufactures and markets pharmaceuticals, various types of medical materials, chemical products, and cosmetics, as well as surgical threads and medical solutions.
